Simulations Plus Inc
SLP
View Detailed Chart
15.860USD
+0.430+2.79%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
319.04MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+2.79%
5 Days
+10.45%
1 Month
+9.76%
6 Months
-37.46%
Year to Date
-43.13%
1 Year
-49.57%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated：2025-09-18Key Insights
The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
6
analysts
Buy
Current Rating
25.333
Target Price
+64.18%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 29.88% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 70.01M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 48.18%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 48.18%.
Undervalued
The company’s latest PE is -5.04, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 20.10M shares, decreasing 10.63% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 1.17M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.61.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Ticker SymbolSLP
CompanySimulations Plus Inc
CEOMr. Shawn M. O'Connor
Websitehttps://www.simulations-plus.com/
Related Instruments
+1.79%
+0.50%
-0.27%
+1.21%
+1.64%
-0.86%
+0.58%
+0.71%
-3.43%
+1.25%
+0.89%
+2.14%
+0.10%
+2.78%
+2.44%
+3.61%
+1.08%
+1.33%
+1.42%
+3.52%
